Amedisys, Inc. (AMED)
NASDAQ: AMED · Real-Time Price · USD
84.47
+0.69 (0.82%)
Dec 20, 2024, 4:00 PM EST - Market closed
Amedisys Revenue
Amedisys had revenue of $587.67M in the quarter ending September 30, 2024, with 5.65% growth. This brings the company's revenue in the last twelve months to $2.32B, up 4.19% year-over-year. In the year 2023, Amedisys had annual revenue of $2.24B with 0.59% growth.
Revenue (ttm)
$2.32B
Revenue Growth
+4.19%
P/S Ratio
1.19
Revenue / Employee
$122,161
Employees
19,000
Market Cap
2.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.24B | 13.18M | 0.59% |
Dec 31, 2022 | 2.22B | 9.09M | 0.41% |
Dec 31, 2021 | 2.21B | 142.59M | 6.88% |
Dec 31, 2020 | 2.07B | 115.89M | 5.93% |
Dec 31, 2019 | 1.96B | 293.06M | 17.63% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 9.47B |
Patterson Companies | 6.55B |
QuidelOrtho | 2.82B |
LifeStance Health Group | 1.21B |
ACADIA Pharmaceuticals | 929.24M |
iRhythm Technologies | 560.03M |
Amicus Therapeutics | 493.67M |
Zai Lab | 355.75M |
AMED News
- 5 weeks ago - US sues to block UnitedHealth's $3.3 bln purchase of Amedisys - Reuters
- 5 weeks ago - US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports - Reuters
- 6 weeks ago - Amedisys Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards - GlobeNewsWire
- 4 months ago - Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model - GlobeNewsWire
- 5 months ago - Amedisys Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - Amedisys Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 9 months ago - Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys - Reuters